RENBP and cancer: KEGG enrichment analysis showed that drug targets were associated with pathways in cancer, neuroactive ligand-receptor interaction, lipid and atherosclerosis, AGE-RAGE signaling pathway in diabetic, cellular senescence, MAPK signaling pathway, TNF signaling pathway, and HIF-1 signaling pathway (Fig. 3D).